López-Hernández, M A <br/><br/>
[Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].  [electronic resource] 

 -  Gaceta medica de Mexico   
 - 145-51 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0016-3813 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--therapeutic use<br/>Carmustine--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>Data Interpretation, Statistical<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Hydrocortisone--therapeutic use<br/>Male<br/>Mercaptopurine--therapeutic use<br/>Methotrexate--therapeutic use<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--therapeutic use<br/>Risk Factors<br/>Time Factors<br/>Vincristine--therapeutic use